Abstract
The effect of joint engagement in 2- to 6-year-old children with ASD was investigated in the largest and the longest observational study to-date. Parents assessed the development of 12081 children quarterly for three years on five subscales: receptive language, expressive language, sociability, sensory awareness, and health. Longer duration of time spent with an adult actively involved in the same activity was associated with improved trajectory of receptive language, expressive language, and sensory awareness. On the annualized basis, the high-joint-engagement group (3 hours or more of joint engagement per day) improved their combinatorial receptive language 1.4-times faster (p=0.0019), expressive language 1.5-times faster (p<0.0001), and sensory awareness 1.5-times faster (p=0.0248) than the low-joint-engagement group (1 hour or less joint engagement per day). The difference in the sociability and the health scores at the end of 3-year study was insignificant. This study confirms the importance of ASD children spending more time with adults actively involved in the same activity and highlights the need to include joint engagement as a target for intervention with this population.
Lay summary Parents of 2- to 6-year-old children with ASD assessed the development of 12081 children quarterly for three years. Longer duration of time spent with an adult actively involved in the same activity was associated with improved developmental trajectory. This study confirms the importance of ASD children spending more time with adults actively involved in the same activity and highlights the need to include joint engagement as a target for intervention with this population.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Using the Department of Health and Human Services regulations found at 45 CFR 46.101(b)(4), the Biomedical Research Alliance of New York LLC Institutional Review Board (IRB) determined that this research project is exempt from IRB oversight.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
